Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-008045
Filing Date
2021-04-14
Accepted
2021-04-14 16:32:02
Documents
1
Period of Report
2021-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5378
  Complete submission text file 0001567619-21-008045.txt   6815
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Moretti August J (Reporting) CIK: 0001344412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39782 | Film No.: 21826074

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)